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Summary 
 
 A total of 168 pigs (average initial BW of 
13.2 lb and avg initial age of 21 d) was used in 
a 35-d experiment to determine the effects of 
mannanoligosaccharides on growth perform-
ance of nursery pigs fed diets without antibiot-
ics.  Treatments were: 1) a positive control 
with carbadox added at 50 g/ton of diet, 2) a 
negative control without antibiotic, 3) the 
negative control with mannanoligosaccharides 
from dried Saccharomyces cerevisiae fermen-
tation solubles (Bio-Mos added at 0.2% of the 
diet), and 4) the negative control diet with 
mannanoligosaccharides from the cell walls of 
yeast (Safmannan added at 0.1% of the diet). 
 
 For d 0 to 7, ADG and F/G was no better 
(P>0.36) for pigs fed the diet with antibiotic 
than the other treatments.  However, this lack 
of difference was the result of good growth 
performance among pigs fed the diets with 
mannanoligosaccharides vs the negative con-
trol (i.e., P<0.07 for ADG and P<0.02 for 
F/G).  For d 0 to 21 and overall (d 0 to 35), 
ADG was greater (P<0.02) for pigs fed diets 
with antibiotic vs the other treatments and for 
pigs fed mannanoligosaccharides vs the nega-
tive control (P<0.04).  However, there were no 
differences in ADG, ADFI, or F/G among pigs 
fed diets with the two different sources of 
mannanoligosaccharides (P>0.49).  Analyses 
of fecal samples indicated no effect of any 
treatment on fecal concentrations of total coli-
forms and E. coli (P>0.54). 
 
 In conclusion, we did observe a positive 
effect of the mannanoligosaccharides on 
growth performance of weanling pigs that was 
intermediate to the nonmedicated and medi-
cated control diets.  Those effects were not 
associated with changes in coliform concen-
trations in the feces and were most likely 
caused by other physiological effects.  
 
(Key Words: Antimicrobial, Nursery Pigs, 
Mannanoligosaccharides) 
 
 
Introduction 
 
 The effects of direct-fed microbials on 
animal growth and health have been of interest 
for many years, especially with the ever-
increasing pressure to reduce (or eliminate) 
subtherapeutic use of antibiotics as non-
specific growth promoters.  A more recent 
thrust has been to identify naturally occurring 
compounds, such as certain fatty acids, pep-
tides, and carbohydrate fractions that have 
biological activity of benefit to growing ani-
mals.  One such group or class of compounds 
that now merits special interest are the man-
nanoligosaccharides. Thus, the experiment 
reported herein was designed to determine the 
effects of two commercially available sources 
of mannanoligosaccharides (fermentation 
solubles vs yeast cell walls) on growth per-
formance in nursery pigs. 
 
Procedures 
 
 A total of 168 pigs (average initial BW of 
13.2 lb and 21 d of age) were used in a 35-d 
experiment to determine the effects of man-
nanoligosaccharides on growth performance 
of nursery pigs fed diets without antibiotics.  
The pigs were sorted by weight and allotted to 
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pens based on gender and ancestry.  There 
were six pigs per pen and seven pens per 
treatment.   
 
 The diets (Table 1) were formulated to: 
1.8% lysine, 0.9% Ca, and 0.8% P for d 0 to 7; 
1.6% lysine, 0.8% Ca, and 0.7% P for d 7 to 
21; and 1.4% lysine, 0.75% Ca, and 0.65% P 
for d 21 to 35.  Treatments were: 1) a positive 
control with carbadox added at 50 g/ton of 
diet, 2) a negative control without antibiotic, 
3) the negative control with mannanoligosac-
charides from dried Saccharomyces cerevisiae 
fermentation solubles (Bio-Mos added at 0.2% 
of the diet), and 4) the negative control diet 
with mannanoligosaccharides from the cell 
walls of yeast (Safmannan added at 0.1% of 
the diet).  The different inclusion amounts for 
the two products were to supply comparable 
amounts of total mannanoligosaccharides.  
 
 For d 0 to 7 and 7 to 21, the diets were 
steam conditioned for approximately 10 sec-
onds at atmospheric pressure and temperatures 
of 140oF and 160oF, respectively.  Pelleting 
was in a CPM Master Model HD1000 pellet 
mill equipped with a 1.25 inch thick die hav-
ing holes with 5/32 inch diameter.  For d 21 to 
35, the diets were fed in meal form.   
 
 The pigs were housed in an environmen-
tally controlled nursery room having 4 × 5 ft 
pens with wire-mesh flooring.  Room tem-
perature initially was 90oF and was decreased 
by 3oF each week thereafter.  The pens had a 
self-feeder and nipple waterer to allow ad libi-
tum consumption of feed and water.  Pig and 
feeder weights were collected on d 0, 7, 21, 
and 35 to allow calculation of ADG, ADFI, 
and F/G.  Additionally, fecal samples were 
collected (by rectal massage) from half of the 
pens on d 38 and the remaining half on d 39.  
On each day, the samples were pooled within 
pen and transferred immediately to a microbi-
ology lab for determination of counts for total 
coliforms and E. coli.  
 
 All data were analyzed (using the GLM 
procedure of SAS) as a completely random-
ized design with gender and initial pen weight 
as covariates. Means were separated with the 
orthogonal contrasts: 1) antibiotic vs all oth-
ers, 2) negative control vs mannanoligosac-
charides, and 3) mannanoligosaccharides from 
fermentation solubles vs those from yeast cell 
walls.   
 
Results and Discussion 
 
 For d 0 to 7, ADG and F/G were no better 
(P>0.36) for pigs fed the diet with antibiotic 
vs the other treatments.  However, this lack of 
difference was the result of good growth per-
formance among pigs fed the diets with man-
nanoligosaccharides vs the negative control 
(i.e., P<0.07 for ADG and P<0.02 for F/G).  
For the two sources of mannanoligosaccha-
rides, ADG was not different (P>0.39), but 
F/G was improved when the mannanoligosac-
charides were from the yeast cell walls 
(P<0.04). 
 
 For d 0 to 21 and overall (d 0 to 35), ADG 
was greater (P<0.02) for pigs fed diets with 
antibiotic vs the other treatments and for pigs 
fed mannanoligosaccharides vs the negative 
control (P<0.04).  Pigs fed the mannanoligo-
saccharides had better F/G than pigs fed the 
negative control (P<0.002).  However, for d 0 
to 21 and 0 to 35, there were no differences in 
ADG, ADFI, or F/G among pigs fed diets with 
the different sources of mannanoligosaccha-
rides (P>0.49). 
 
 In addition to the data for growth perform-
ance, we collected fecal samples to evaluate 
changes in the intestinal environment.  There 
was a trend (P<0.09) for greater pH of the fe-
ces in pigs fed diets with the mannanoligosac-
charides vs the negative control, but this 
change in pH did not affect counts for total 
coliforms and E. coli (P>0.65).  Indeed, analy-
ses of the fecal samples indicated no effect of 
any treatment on fecal concentrations of total 
coliforms and E. coli (P>0.54).  Thus, it ap-
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pears that the positive effects of the antibiotic 
and mannanoligosaccharides on growth per-
formance were not associated with changes in 
the gut microflora we evaluated. 
 
 In conclusion, we did observe a positive 
effect of the mannanoligosaccharides on 
growth performance of weanling pigs that was 
intermediate to the nonmedicated and medi-
cated control diets.  Those effects were not 
associated with changes in coliform concen-
trations in the feces and were most likely 
caused by other physiological effects. 
 
 
 
 Table 1.  Composition of Diets 
Item d 0 to 7 d 7 to 21 d 21 to 35 
Ingredient, %   
  Corn 
  Soybean meal 
  Edible grade whey 
  Spray-dried animal plasma  
  Spray-dried wheat gluten 
  Fishmeal 
  Soybean oil 
  Lysine HCl 
  DL-methionine 
  Threonine 
  Limestone 
  Monocalcium phosphate 
  Salt 
  Vitamin premix 
  Mineral premix 
  Antibiotic/mannansa 
 
Calculated composition 
  CP, % 
  Total lysine, % 
  Ca, % 
  Total P, % 
  ME, kcal/lb 
 
38.95 
23.84 
20.00 
5.00 
5.00 
2.00 
2.00 
0.38 
0.12 
0.07 
1.00 
1.06 
0.20 
0.25 
0.15 
- 
 
 
26.3 
1.80 
0.90 
0.80 
1,539 
 
49.44 
27.71 
10.00 
2.00 
- 
5.00 
3.50 
0.21 
0.10 
0.07 
0.73 
0.53 
0.30 
0.25 
0.15 
- 
 
 
23.4 
1.60 
0.80 
0.70 
1,584 
 
57.93 
33.42 
- 
- 
- 
- 
5.00 
0.31 
0.12 
0.11 
1.15 
1.22 
0.35 
0.25 
0.15 
- 
 
 
21.1 
1.40 
0.75 
0.65 
1,604 
aProvided 50 g of carbadox/ton of feed for the diets with antibiotic or 0.2% Bio-Mos or 0.1% 
Safmannan for the diets with mannanoligosaccharides. 
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Table 2.  Effects of Mannanoligosaccharides on Growth Performance of Nursery Pigsa 
      Contrastsb 
 
Item 
 
Antibiotic 
 
None 
Bio- 
Mos 
Saf- 
mannan
 
SE 
Antibiotic 
vs others 
None vs 
mannans 
Bio-Mos vs 
Safmannan
 d 0 to 7 
    ADG, lb 
    ADFI, lb 
    F/G 
d 0 to 21 
    ADG, lb 
    ADFI, lb 
    F/G 
Overall (d 0 to 35) 
    ADG, lb 
    ADFI, lb 
    F/G 
Fecal analyses 
pH 
Coliforms, log10 
E. coli, log10 
 
0.54 
0.48 
0.89 
 
0.73 
0.82 
1.12 
 
1.01 
1.33 
1.32 
 
6.00 
5.53 
5.21 
 
0.45 
0.43 
0.96 
 
0.60 
0.73 
1.22 
 
0.87 
1.24 
1.43 
 
5.87 
5.65 
5.43 
 
0.51 
0.46 
0.90 
 
0.68 
0.78 
1.15 
 
0.94 
1.24 
1.32 
 
6.00 
6.04 
5.70 
 
0.55 
0.45 
0.82 
 
0.66 
0.76 
1.15 
 
0.94 
1.23 
1.31 
 
6.01 
5.77 
5.58 
 
0.03
0.02
0.10
 
0.03
0.03
0.03
 
0.02
0.03
0.02
 
0.06
0.45
0.49
 
–c 
– 
– 
 
0.02 
0.04 
0.05 
 
0.002
0.02 
0.11 
 
– 
– 
– 
 
0.07 
– 
0.02 
 
0.04 
– 
0.002 
 
0.04 
– 
0.001 
 
0.09 
– 
– 
 
– 
– 
0.04 
 
– 
– 
– 
 
– 
– 
– 
 
– 
– 
– 
aA total of 168 pigs (six pigs per pen and seven pens per treatment) with an average initial BW of 
13.2lb and an average initial age of 21 d.  
bContrasts were: 1) antibiotic vs all others, 2) negative control vs mannanoligosaccharides, and 3) 
mannanoligosaccharides from fermentation solubles (Bio-Mos) vs yeast cell walls (Safmannan). 
cDashes indicate P=0.15 or greater.  
